Cargando…

Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells

OBJECTIVES: To describe histological, immunohistochemical and ultrastructural features of synovial biopsies of amyloid arthropathy associated with multiple myeloma (MM). METHODS: Synovial biopsies from affected joints of two patients with MM and amyloid arthropathy were examined with light and elect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pessler, Frank, Ogdie, Alexis R., Mayer, Christian T., Kretzschmar, Warren W., Dai, Lie, Elsaman, Ahmed M., Einhorn, Eugene, Krenn, Veit, Schumacher, H. Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa UK Ltd. 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956491/ https://www.ncbi.nlm.nih.gov/pubmed/24286442 http://dx.doi.org/10.3109/13506129.2013.862229

Ejemplares similares

Myeloma-associated amyloid arthropathy masquerading as seronegative arthritis
por: Garg, Akanksha, et al.
Publicado: (2020)

Amyloid arthropathy in smoldering myeloma: Do not take it lightly
por: Muchtar, Eli, et al.
Publicado: (2021)

The Relative Composition of the Inflammatory Infiltrate as an Additional Tool for Synovial Tissue Classification
por: Della Beffa, Cristina, et al.
Publicado: (2013)

Amyloid Arthropathy of the Hip Joint Associated with Multiple Myeloma: A Case Report
por: Cho, Yoon Je, et al.
Publicado: (2016)

Multiple myeloma presenting with amyloid arthropathy as the first manifestation: Two case reports
por: He, Chuan, et al.
Publicado: (2022)

Seronegative rheumatoid arthritis as the first manifestation of multiple myeloma-associated amyloid arthropathy
por: Wang, Gang, et al.
Publicado: (2023)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

The Anti-CD38 Antibody Therapy in Multiple Myeloma
por: Petrucci, Maria Teresa, et al.
Publicado: (2019)

CD38-Directed Therapies for Management of Multiple Myeloma
por: Hashmi, Hamza, et al.
Publicado: (2021)

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
por: Chemlal, Djamila, et al.
Publicado: (2023)

Multimodality Imaging Including PET/CT in a Patient with Amyloid Arthropathy and Multiple Myeloma
por: dos Reis Teixeira, Afrânio, et al.
Publicado: (2016)

Radiologic Findings in Polyarticular Amyloid Arthropathy and Myopathy in Multiple Myeloma: A Case Report
por: Khoo, Hau Wei, et al.
Publicado: (2018)

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
por: Zannetti, Beatrice Anna, et al.
Publicado: (2020)

Leucocyte Abnormalities in Synovial Fluid of Degenerative and Inflammatory Arthropathies
por: Baggio, Chiara, et al.
Publicado: (2023)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2020)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis
por: MURAKAMI, Kohei, et al.
Publicado: (2015)

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
por: Costa, Federica, et al.
Publicado: (2017)

Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma
por: Fayon, Maxime, et al.
Publicado: (2021)

Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
por: Jeong, Tae-Dong, et al.
Publicado: (2012)

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
por: van de Donk, Niels W.C.J., et al.
Publicado: (2018)

Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
por: Wu, Hao-Tian, et al.
Publicado: (2022)

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma
por: Omstead, David T., et al.
Publicado: (2020)

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
por: Bartosińska, Joanna, et al.
Publicado: (2021)

Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
por: Franssen, Laurens E., et al.
Publicado: (2020)

A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma
por: Li, Hongwen, et al.
Publicado: (2023)

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
por: Bisht, Kamlesh, et al.
Publicado: (2023)

Increased Ratio of CD14(++)CD80(+) Cells/CD14(++)CD163(+) Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients
por: Ma, Shuhe, et al.
Publicado: (2021)

Multimodality Molecular Imaging in Arthropathy Associated with Multiple Myeloma
por: Almeida, Ludmila Santiago, et al.
Publicado: (2022)

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
por: Pouleau, Blandine, et al.
Publicado: (2023)

Synovial Cell Count Poorly Predicts Septic Arthritis in the Presence of Crystalline Arthropathy
por: Luo, T. David, et al.
Publicado: (2020)

Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
por: Bannas, Peter, et al.
Publicado: (2018)

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2016)

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients
por: Frerichs, Kristine A., et al.
Publicado: (2019)

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma
por: Kinder, Michelle, et al.
Publicado: (2021)

CD38 – Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report
por: Thi Vinh Do, An, et al.
Publicado: (2022)

Synovial tissues concentrate secreted APRIL
por: Gabay, Cem, et al.
Publicado: (2009)

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies
por: Verkleij, Christie P. M., et al.
Publicado: (2020)

Parathyreoidectomy in Ankylosing Polyarthritis
Publicado: (1936)

Cannot write session to /tmp/vufind_sessions/sess_fb44gor011pm16v88le2bmj18p